245 related articles for article (PubMed ID: 33845854)
1. Aspartame and cancer - new evidence for causation.
Landrigan PJ; Straif K
Environ Health; 2021 Apr; 20(1):42. PubMed ID: 33845854
[TBL] [Abstract][Full Text] [Related]
2. Pathologists' perspective on the study design, analysis, and interpretation of proliferative lesions in lifetime and prenatal rodent carcinogenicity bioassays of aspartame.
Elmore SA; Rehg JE; Schoeb TR; Everitt JI; Bolon B
Food Chem Toxicol; 2023 Jan; 171():113504. PubMed ID: 36414169
[TBL] [Abstract][Full Text] [Related]
3. Aspartame, a bittersweet pill.
Paolini M; Vivarelli F; Sapone A; Canistro D
Carcinogenesis; 2017 Dec; 38(12):1249-1250. PubMed ID: 26912665
[TBL] [Abstract][Full Text] [Related]
4. Life-span exposure to low doses of aspartame beginning during prenatal life increases cancer effects in rats.
Soffritti M; Belpoggi F; Tibaldi E; Esposti DD; Lauriola M
Environ Health Perspect; 2007 Sep; 115(9):1293-7. PubMed ID: 17805418
[TBL] [Abstract][Full Text] [Related]
5. Identification of aspartame-induced haematopoietic and lymphoid tumours in rats after lifetime treatment.
Tibaldi E; Gnudi F; Panzacchi S; Mandrioli D; Vornoli A; Manservigi M; Sgargi D; Falcioni L; Bua L; Belpoggi F
Acta Histochem; 2020 Jul; 122(5):151548. PubMed ID: 32622430
[TBL] [Abstract][Full Text] [Related]
6. Histological analyses of the Ishii (1981) rat carcinogenicity study of aspartame and comparison with the Ramazzini Institute studies.
Shibui Y; Fujitani S; Iwata H; Lynch B; Roberts A
Regul Toxicol Pharmacol; 2019 Mar; 102():23-29. PubMed ID: 30572082
[TBL] [Abstract][Full Text] [Related]
7. Hemolymphoreticular Neoplasias from the Ramazzini Institute Long-term Mice and Rat Studies on Aspartame.
Gnudi F; Panzacchi S; Tibaldi E; Iuliani M; Sgargi D; Bua L; Mandrioli D
Ann Glob Health; 2023; 89(1):43. PubMed ID: 37362827
[TBL] [Abstract][Full Text] [Related]
8. NTP report on the toxicology studies of aspartame (CAS No. 22839-47-0) in genetically modified (FVB Tg.AC hemizygous) and B6.129-Cdkn2atm1Rdp (N2) deficient mice and carcinogenicity studies of aspartame in genetically modified [B6.129-Trp53tm1Brd (N5) haploinsufficient] mice (feed studies).
National Toxicology Program
Natl Toxicol Program Genet Modif Model Rep; 2005 Oct; (1):1-222. PubMed ID: 18685711
[TBL] [Abstract][Full Text] [Related]
9. First experimental demonstration of the multipotential carcinogenic effects of aspartame administered in the feed to Sprague-Dawley rats.
Soffritti M; Belpoggi F; Degli Esposti D; Lambertini L; Tibaldi E; Rigano A
Environ Health Perspect; 2006 Mar; 114(3):379-85. PubMed ID: 16507461
[TBL] [Abstract][Full Text] [Related]
10. Aspartame, low-calorie sweeteners and disease: regulatory safety and epidemiological issues.
Marinovich M; Galli CL; Bosetti C; Gallus S; La Vecchia C
Food Chem Toxicol; 2013 Oct; 60():109-15. PubMed ID: 23891579
[TBL] [Abstract][Full Text] [Related]
11. Results of long-term carcinogenicity bioassay on Sprague-Dawley rats exposed to aspartame administered in feed.
Belpoggi F; Soffritti M; Padovani M; Degli Esposti D; Lauriola M; Minardi F
Ann N Y Acad Sci; 2006 Sep; 1076():559-77. PubMed ID: 17119233
[TBL] [Abstract][Full Text] [Related]
12. Nephrotoxic Effect of Aspartame as an Artificial Sweetener: a Brief Review.
Ardalan MR; Tabibi H; Ebrahimzadeh Attari V; Malek Mahdavi A
Iran J Kidney Dis; 2017 Oct; 11(5):339-343. PubMed ID: 29038387
[TBL] [Abstract][Full Text] [Related]
13. Acceptable daily intake and the regulation of intense sweeteners.
Renwick AG
Food Addit Contam; 1990; 7(4):463-75. PubMed ID: 1697543
[TBL] [Abstract][Full Text] [Related]
14. Intake of intense sweeteners in Germany.
Bär A; Biermann C
Z Ernahrungswiss; 1992 Mar; 31(1):25-39. PubMed ID: 1374988
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic effect of aspartame (diet sweet) on the histological and genetic structures of female albino rats and their offspring.
Abd Elfatah AA; Ghaly IS; Hanafy SM
Pak J Biol Sci; 2012 Oct; 15(19):904-18. PubMed ID: 24159687
[TBL] [Abstract][Full Text] [Related]
16. Aspartame and Risk of Cancer: A Meta-analytic Review.
Mallikarjun S; Sieburth RM
Arch Environ Occup Health; 2015; 70(3):133-41. PubMed ID: 24965331
[TBL] [Abstract][Full Text] [Related]
17. Sour finding on popular sweetener.
Mead MN
Environ Health Perspect; 2006 Mar; 114(3):A176. PubMed ID: 16528837
[No Abstract] [Full Text] [Related]
18. Aspartame: a safety evaluation based on current use levels, regulations, and toxicological and epidemiological studies.
Magnuson BA; Burdock GA; Doull J; Kroes RM; Marsh GM; Pariza MW; Spencer PS; Waddell WJ; Walker R; Williams GM
Crit Rev Toxicol; 2007; 37(8):629-727. PubMed ID: 17828671
[TBL] [Abstract][Full Text] [Related]
19. Trends and amounts of consumption of low-calorie sweeteners: A cross-sectional study.
Daher M; Fahd C; Nour AA; Sacre Y
Clin Nutr ESPEN; 2022 Apr; 48():427-433. PubMed ID: 35331524
[TBL] [Abstract][Full Text] [Related]
20. Lack of potential carcinogenicity for aspartame - Systematic evaluation and integration of mechanistic data into the totality of the evidence.
Wikoff DS; Chappell GA; Fitch S; Doepker CL; Borghoff SJ
Food Chem Toxicol; 2020 Jan; 135():110866. PubMed ID: 31614175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
